Securities code: 688133 securities abbreviation: Shanghai Titan Scientific Co.Ltd(688133) Announcement No.: 2021-086 Shanghai Titan Scientific Co.Ltd(688133)
Announcement on resolutions of the 19th meeting of the third board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law. 1、 Convening of board meeting
Shanghai Titan Scientific Co.Ltd(688133) (hereinafter referred to as “the company” or ” Shanghai Titan Scientific Co.Ltd(688133) “) convened the 19th meeting of the third board of directors of the company (hereinafter referred to as “the meeting”) by means of on-site meeting and communication on December 30, 2021. The notice of this meeting was notified to all directors by telephone on the evening of December 29, 2021. Due to the emergency, the convener explained, and all directors unanimously agreed to waive the notice time limit of this meeting. There were 9 directors who should attend the meeting, and 9 actually attended the meeting. The meeting was presided over by Mr. Xie Yingbo, chairman of the company, and other relevant personnel of the company attended the meeting as nonvoting delegates. The convening and convening of the meeting comply with the company law of the people’s Republic of China and the Shanghai Titan Scientific Co.Ltd(688133) articles of Association (hereinafter referred to as the “articles of association”) and other relevant provisions, and the resolutions formed by voting are legal and effective.
2、 Deliberations of the board meeting
The meeting was presided over by Mr. Xie Yingbo, chairman of the board. After voting by all directors, the following resolutions were formed:
(i) The proposal on adjusting the company’s plan to issue A-Shares to specific objects in 2021 was deliberated and adopted
The company’s proposal on issuing A-Shares to specific objects in 2021 (hereinafter referred to as the “issuance plan”) has been deliberated and adopted at the 12th meeting of the third board of directors and the second extraordinary general meeting of shareholders in 2021 on July 5, 2021 and July 22, 2021 respectively. In accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the measures for the administration of securities issuance and registration of companies listed on the science and Innovation Board (for Trial Implementation), the detailed rules for the implementation of securities issuance and underwriting of companies listed on the science and innovation board, and the authorization of the second extraordinary general meeting of shareholders in 2021, the board of directors of the company adjusted the issuance plan. The specific contents are as follows:
1. Amount and purpose of raised funds
Before this revision:
The total amount of A-Shares issued to specific objects this time shall not exceed 1054345900 yuan (including this amount). The net amount of the total amount of funds raised this time after deducting the issuance expenses will be used in the following directions:
Unit: 10000 yuan
Total investment of the project to be invested by the raised funds
forehead
1 Shanghai Titan Scientific Co.Ltd(688133) life science headquarters park project 77434.5977434.59
2. Supplementary working capital project 28000.0028000.00
Total 105434.59
Within the scope of the above raised capital investment projects, the company can appropriately adjust the investment sequence and specific amount of the corresponding raised capital investment projects according to the actual situation such as project progress and capital demand. Before the raised funds are in place, the company may, according to the actual situation of the projects invested with the raised funds, invest with the self raised funds first, and replace them after the raised funds are in place. After the raised funds are in place, if the actual net amount of raised funds after deducting the issuance expenses is less than the total amount of raised funds to be invested, the insufficient part shall be solved by the company with self raised funds.
If the total amount of funds raised by this issuance to specific objects is adjusted due to changes in regulatory policies or the requirements of issuance registration documents, it will be adjusted accordingly at that time.
After this revision:
The total amount of A-Shares issued to specific objects this time shall not exceed 1023345900 yuan (including this amount). The net amount of the total amount of funds raised this time after deducting the issuance expenses will be used in the following directions:
Unit: 10000 yuan
Total investment of the project to be invested by the raised funds
forehead
1 Shanghai Titan Scientific Co.Ltd(688133) life science headquarters park project 77434.5977434.59
2. Supplementary working capital project 24900.0024900.00
Total 102334.59
Within the scope of the above raised capital investment projects, the company can appropriately adjust the investment sequence and specific amount of the corresponding raised capital investment projects according to the actual situation such as project progress and capital demand. Before the raised funds are in place, the company may, according to the actual situation of the projects invested with the raised funds, invest with the self raised funds first, and replace them after the raised funds are in place. After the raised funds are in place, if the actual net amount of raised funds after deducting the issuance expenses is less than the total amount of raised funds to be invested, the insufficient part shall be solved by the company with self raised funds.
If the total amount of funds raised by this issuance to specific objects is adjusted due to changes in regulatory policies or the requirements of issuance registration documents, it will be adjusted accordingly at that time.
Voting results: 9 in favor, 0 against and 0 abstention.
Independent directors have expressed their independent opinions on the above matters.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com.. CN.) The Shanghai Titan Scientific Co.Ltd(688133) announcement on adjusting the company’s plan to issue A-Shares to specific objects in 2021 (Announcement No.: 2021-089) disclosed.
（2） The proposal on the company’s plan for issuing A-Shares to specific objects in 2021 (Revised Draft) was reviewed and adopted
Due to the company’s adjustment of the relevant contents of the A-share issuance plan to specific objects, the company has prepared the plan for issuing A-share shares to specific objects in Shanghai Titan Scientific Co.Ltd(688133) 2021 (Revised). For details, see the company’s disclosure on the website of Shanghai Stock Exchange on the same day (www.sse. Com.. CN.) Plan for issuing A-Shares to specific objects in Shanghai Titan Scientific Co.Ltd(688133) 2021 (Revised Version). Voting results: 9 in favor, 0 against and 0 abstention.
Independent directors have expressed their independent opinions on the above matters.
（3） The proposal on the demonstration and analysis report (Revised Draft) of the company’s A-share issuance scheme to specific objects in 2021 was reviewed and approved
As the company adjusted the relevant contents of the A-share issuance scheme to specific objects, the company prepared the demonstration and analysis report on the A-share issuance scheme to specific objects in Shanghai Titan Scientific Co.Ltd(688133) 2021 (Revised Version). For details, see the company’s disclosure on the website of Shanghai Stock Exchange on the same day (www.sse. Com.. CN.) Demonstration and analysis report on the issuance scheme of A-Shares issued to specific objects in Shanghai Titan Scientific Co.Ltd(688133) 2021 (Revised Version).
Voting results: 9 in favor, 0 against and 0 abstention.
Independent directors have expressed their independent opinions on the above matters.
（4） The proposal on the feasibility analysis report (Revised Draft) on the use of funds raised by the company’s issuance of A-Shares to specific objects in 2021 was reviewed and approved
As the company adjusted the relevant contents of the issuance plan for issuing A-Shares to specific objects, the company prepared the feasibility analysis report on the application of funds raised by issuing A-Shares to specific objects in Shanghai Titan Scientific Co.Ltd(688133) 2021 (Revised Version). For details, see the company’s disclosure on the website of Shanghai Stock Exchange on the same day (www.sse. Com.. CN.) Feasibility analysis report on the use of funds raised by issuing A-Shares to specific objects in Shanghai Titan Scientific Co.Ltd(688133) 2021 (Revised Version).
Voting results: 9 in favor, 0 against and 0 abstention.
Independent directors have expressed their independent opinions on the above matters.
（5） The proposal on diluting the immediate return and filling measures for the company’s issuance of A-Shares to specific objects in 2021 and the commitments of relevant subjects (Revised Draft) were reviewed and adopted
Due to the company’s adjustment of the relevant contents of the issuance plan for issuing A-Shares to specific objects, the company makes corresponding synchronous adjustment on the impact of the issuance of A-Shares to specific objects on the immediate diluted return, the measures to fill the return and the commitments of relevant subjects. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com.. CN.) disclosed by the company on the same day Announcement of Shanghai Titan Scientific Co.Ltd(688133) on diluting the immediate return of issuing A-Shares to specific objects, the company’s filling measures and the commitments of relevant subjects (Revised Version) (Announcement No.: 2021-091). Voting results: 9 in favor, 0 against and 0 abstention.
Independent directors have expressed their independent opinions on the above matters.
It is hereby announced.
Shanghai Titan Scientific Co.Ltd(688133) board of directors December 31, 2021
